A Phase 2, Randomized, Double-Blind, does-finding, Parallel Group, Multi-Center Study to evaluate Efficacy and Safety of M118103 in Subjects with Prurigo nodularis.
Phase II study of M118103 in the treatment of nodular prurigo which does not respond to topical steroid treatment
Phase II study of M118103 in the treatment of nodular prurigo which does not respond to topical steroid treatment
100 项与 M-118103 相关的专利(医药)